Novartis lung cancer drug Tabrecta gets approval : vimarsana

Novartis receives approval from the European Commission for Tabrecta for the treatment of non-small cell lung cancer - News - PharmaTimes

Related Keywords

Liechtenstein , Germany , Norway , Iceland , Japan , Switzerland , Juergen Wolf , European Union , European Commission For Tabrecta , European Commission , University Hospital Cologne , Novartis , Medicinal Products , Human Use , European Medicines Agency , Integrated Oncology , Lung Cancer , Abrecta ,